Haemodynamic Effects of Combined Oral Nifedipine and Sublingual Nitroglycerin in Patients with Chronic Stable Angina

Overview

Journal Eur J Clin Pharmacol

Specialty Pharmacology

Date 1987 Jan 1

PMID 3127220

Authors

K M Boje

H L Fung

K Yoshitomi

J O PARKER

Affiliations

Soon will be listed here.

Abstract

We examined the pharmacokinetics of nifedipine after acute and sustained oral therapy and the potential haemodynamic interaction between nifedipine and sublingual nitroglycerin in nine patients with chronic stable angina. Nifedipine pharmacokinetics after a single oral dose and sustained dosing (three times daily for five days) were not significantly different. Single dose nifedipine produced a statistically significant decrease in standing and supine systolic and diastolic blood pressures when compared to placebo. A significant decrease in the supine systolic pressure was observed after sustained nifedipine therapy. Except for this change, other hypotensive effects of nifedipine after sustained therapy were not different to those of placebo, in spite of persistent plasma nifedipine concentrations after repeated dosing. There were no observable correlations between nifedipine haemodynamics and pharmacokinetics in these patients, nor were there any significant haemodynamic interactions between sublingual nitroglycerin with either acute or sustained nifedipine treatment. The transient haemodynamic effects of sublingual nitroglycerin were not potentiated by either acute or sustained nifedipine therapy.

References

FELDMAN R, Hill J, Conti J, Conti C, Pepine C . Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease. Am Heart J. 1983; 105(4):651-8. DOI: 10.1016/0002-8703(83)90490-8. View

Traube M, Hongo M, McAllister Jr R, McCallum R . Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. J Clin Pharmacol. 1985; 25(2):125-9. DOI: 10.1002/j.1552-4604.1985.tb02812.x. View

Kanda K, Flaim S . Effects of nifedipine on total cardiac output distribution in conscious rat. J Pharmacol Exp Ther. 1984; 228(3):711-8. View

RIGGS D, Guarnieri J, Addelman S . Fitting straight lines when both variables are subject to error. Life Sci. 1978; 22(13-15):1305-60. DOI: 10.1016/0024-3205(78)90098-x. View

Kleinbloesem C, van Brummelen P, van de Linde J, Voogd P, Breimer D . Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther. 1984; 35(6):742-9. DOI: 10.1038/clpt.1984.105. View

Cohen D, Foley R, Ryan J . Intraoperative coronary artery spasm successfully treated with nitroglycerin and nifedipine. Ann Thorac Surg. 1983; 36(1):97-100. DOI: 10.1016/s0003-4975(10)60659-5. View

Husted S, Nielsen H, Christensen C, Lederballe Pedersen O . Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent. Eur J Clin Pharmacol. 1982; 22(2):101-3. DOI: 10.1007/BF00542452. View

Kleinbloesem C, van Brummelen P, Danhof M, Faber H, Urquhart J, Breimer D . Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther. 1987; 41(1):26-30. DOI: 10.1038/clpt.1987.5. View

Kleinbloesem C, van Brummelen P, Faber H, Breimer D . Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients. J Cardiovasc Pharmacol. 1987; 9(2):202-8. DOI: 10.1097/00005344-198702000-00012. View

10.

Yap P, McNiff E, Fung H . Improved GLC determination of plasma nitroglycerin concentrations. J Pharm Sci. 1978; 67(4):582-4. DOI: 10.1002/jps.2600670445. View

11.

Rocci Jr M, Jusko W . LAGRAN program for area and moments in pharmacokinetic analysis. Comput Programs Biomed. 1983; 16(3):203-16. DOI: 10.1016/0010-468x(83)90082-x. View

12.

Feely J . Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects. Br J Clin Pharmacol. 1984; 17(1):83-5. PMC: 1463307. DOI: 10.1111/j.1365-2125.1984.tb05003.x. View

13.

Wilkinson G, SHAND D . Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975; 18(4):377-90. DOI: 10.1002/cpt1975184377. View

14.

Fung H, Blei A, Chong S . Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats. J Pharmacol Exp Ther. 1986; 239(3):701-5. View

15.

Pang K, Rowland M . Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm. 1977; 5(6):625-53. DOI: 10.1007/BF01059688. View

16.

FOSTER T, Hamann S, Richards V, Bryant P, Graves D, McALLISTER R . Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol. 1983; 23(4):161-70. DOI: 10.1002/j.1552-4604.1983.tb02720.x. View

17.

Kubo S, Fox S, Prida X, Cody R . Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. Am Heart J. 1985; 110(5):1032-4. DOI: 10.1016/0002-8703(85)90205-4. View

18.

Boje K, DOLCE J, Fung H . Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study. Res Commun Chem Pathol Pharmacol. 1984; 46(2):219-26. View

19.

Blei A, Gottstein J, Fung H . Role of the liver in the disposition of intravenous nitroglycerin in the rat. Biochem Pharmacol. 1984; 33(16):2681-6. DOI: 10.1016/0006-2952(84)90645-2. View

20.

Armstrong P, Armstrong J, Marks G . Blood levels after sublingual nitroglycerin. Circulation. 1979; 59(3):585-8. DOI: 10.1161/01.cir.59.3.585. View